Results 91 to 100 of about 510,744 (297)

Recurrent cancer‐associated ERBB4 mutations are transforming and confer resistance to targeted therapies

open access: yesMolecular Oncology, EarlyView.
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala   +15 more
wiley   +1 more source

Human vaccines & immunotherapeutics: News June 2023

open access: yesHuman Vaccines & Immunotherapeutics, 2023
Ronald Ellis, Adam Weiss
doaj   +1 more source

A Practical Perspective on Human Capital Post Merger Integration in Central and Eastern Europe [PDF]

open access: yes
Driven by a philosophy of shareholder value, mergers and acquisitions form a new economic, social and cultural environment. It is only by a profound understanding of the success factors in mergers and acquisitions that they are able to improve ...
Marian-Adrian GROSU   +1 more
core  

Peroxidasin enables melanoma immune escape by inhibiting natural killer cell cytotoxicity

open access: yesMolecular Oncology, EarlyView.
Peroxidasin (PXDN) is secreted by melanoma cells and binds the NK cell receptor NKG2D, thereby suppressing NK cell activation and cytotoxicity. PXDN depletion restores NKG2D signaling and enables effective NK cell–mediated melanoma killing. These findings identify PXDN as a previously unrecognized immune evasion factor and a potential target to improve
Hsu‐Min Sung   +17 more
wiley   +1 more source

Human vaccines & immunotherapeutics: News January 2023

open access: yesHuman Vaccines & Immunotherapeutics, 2023
Ronald Ellis, Adam Weiss
doaj   +1 more source

Crucial parameters for precise copy number variation detection in formalin‐fixed paraffin‐embedded solid cancer samples

open access: yesMolecular Oncology, EarlyView.
This study shows that copy number variations (CNVs) can be reliably detected in formalin‐fixed paraffin‐embedded (FFPE) solid cancer samples using ultra‐low‐pass whole‐genome sequencing, provided that key (pre)‐analytical parameters are optimized.
Hanne Goris   +10 more
wiley   +1 more source

Human vaccines & immunotherapeutics: News August 2023

open access: yesHuman Vaccines & Immunotherapeutics, 2023
Ronald Ellis, Adam Weiss
doaj   +1 more source

An analysis of mergers and acquisitions in the Turkish banking sector [PDF]

open access: yes
We explore various aspects of mergers and acquisitions in the banking industry within a simple model that allows explicit comparison of sector performance before and after the mergers and acquisitions.
Mumcu, Ayşe, Zenginobuz, Unal
core   +1 more source

Phenotypic and genotypic characterization of single circulating tumor cells in the follow‐up of high‐grade serous ovarian cancer

open access: yesMolecular Oncology, EarlyView.
Single circulating tumor cells (sCTCs) from high‐grade serous ovarian cancer patients were enriched, imaged, and genomically profiled using WGA and NGS at different time points during treatment. sCTCs revealed enrichment of alterations in Chromosomes 2, 7, and 12 as well as persistent or emerging oncogenic CNAs, supporting sCTC identity.
Carolin Salmon   +9 more
wiley   +1 more source

Human vaccines & immunotherapeutics: News October 2023

open access: yesHuman Vaccines & Immunotherapeutics, 2023
Ronald Ellis, Adam Weiss
doaj   +1 more source

Home - About - Disclaimer - Privacy